Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Pharmacy education and practice in 13 Middle Eastern countries.

Kheir N, Zaidan M, Younes H, El Hajj M, Wilbur K, Jewesson PJ.

Am J Pharm Educ. 2008 Dec 15;72(6):133.

2.

Documenting drug-related problems with personal digital assistants in a multisite health system.

Raybardhan S, Balen RM, Partovi N, Loewen P, Liu G, Jewesson PJ.

Am J Health Syst Pharm. 2005 Sep 1;62(17):1782-7.

PMID:
16120737
4.

Willingness to pay to assess patient preferences for therapy in a Canadian setting.

Marra CA, Frighetto L, Goodfellow AF, Wai AO, Chase ML, Nicol RE, Leong CA, Tomlinson S, Ferreira BM, Jewesson PJ.

BMC Health Serv Res. 2005 Jun 7;5:43.

5.

Pharmacist computer skills and needs assessment survey.

Balen RM, Jewesson PJ.

J Med Internet Res. 2004 Mar 29;6(1):e11.

6.

Industry sponsorship and authorship of clinical trials over 20 years.

Buchkowsky SS, Jewesson PJ.

Ann Pharmacother. 2004 Apr;38(4):579-85. Epub 2004 Feb 24. Review.

PMID:
14982982
7.

Delivery of multimedia educational presentations via streaming media.

Chong E, Balen RM, Jewesson PJ.

Am J Health Syst Pharm. 2003 Dec 1;60(23):2475-8. No abstract available.

PMID:
14686223
8.
9.
10.
11.

Quality-of-life assessment in an outpatient parenteral antibiotic program.

Goodfellow AF, Wai AO, Frighetto L, Marra CA, Ferreira BM, Chase ML, Nicol RE, Leong CA, Tomlinson S, Jewesson PJ.

Ann Pharmacother. 2002 Dec;36(12):1851-5.

PMID:
12452743
12.
13.

A response to the ACP-ASIM position paper on pharmacist scope of practice.

Zed PJ, Loewen PS, Jewesson PJ.

Am J Health Syst Pharm. 2002 Aug 1;59(15):1453-6. No abstract available.

PMID:
12166047
14.

Amphotericin B-loaded bone cement to treat osteomyelitis caused by Candida albicans.

Marra F, Robbins GM, Masri BA, Duncan C, Wasan KM, Kwong EH, Jewesson PJ.

Can J Surg. 2001 Oct;44(5):383-6. No abstract available.

15.
16.

A new ciprofloxacin stepdown program in the treatment of high-risk febrile neutropenia: a clinical and economic analysis.

Marra CA, Frighetto L, Quaia CB, de Lemos ML, Warkentin DI, Marra F, Jewesson PJ.

Pharmacotherapy. 2000 Aug;20(8):931-40.

PMID:
10939554
17.

Economic impact of standardized orders for antimicrobial prophylaxis program.

Frighetto L, Marra CA, Stiver HG, Bryce EA, Jewesson PJ.

Ann Pharmacother. 2000 Feb;34(2):154-60.

PMID:
10676821
18.

Continuous intrathecal pump infusion of baclofen with antibiotic drugs for treatment of pump-associated meningitis. Case report.

Zed PJ, Stiver HG, Devonshire V, Jewesson PJ, Marra F.

J Neurosurg. 2000 Feb;92(2):347-9.

PMID:
10659025
19.

Cost-minimization analysis of piperacillin/tazobactam versus imipenem/cilastatin for the treatment of serious infections: a Canadian hospital perspective.

Marra FO, Frighetto LO, Marra CA, Sleigh KM, Stiver HG, Bryce EA, Reynolds RP, Jewesson PJ.

Ann Pharmacother. 1999 Feb;33(2):156-62.

PMID:
10084409
20.

Tracking and reporting drug expenditures.

Frighetto L, Marra CA, Jewesson PJ.

Am J Health Syst Pharm. 1997 Oct 15;54(20):2302, 2305-6. No abstract available.

PMID:
9347103
21.

Evaluation of the use of cefuroxime and cefuroxime axetil in an intravenous-oral stepdown program.

Malfair SC, Frighetto L, Nickoloff DM, Martinusen SM, Jewesson PJ.

Ann Pharmacother. 1996 Apr;30(4):337-42.

PMID:
8729884
22.

Double-blind comparison of cefazolin and ceftizoxime for prophylaxis against infections following elective biliary tract surgery.

Jewesson PJ, Stiver G, Wai A, Frighetto L, Nickoloff D, Smith J, Schwartz L, Sleigh K, Danforth D, Scudamore C, Chow A.

Antimicrob Agents Chemother. 1996 Jan;40(1):70-4.

23.

Sequential antibiotic therapy: Effective cost management and patient care.

Mandell LA, Bergeron MG, Gribble MJ, Jewesson PJ, Low DE, Marrie TJ, Nicolle LE.

Can J Infect Dis. 1995 Nov;6(6):306-15.

24.

Amphotericin B infusion-related toxicity: comparison of two- and four-hour infusions.

Nicholl TA, Nimmo CR, Shepherd JD, Phillips P, Jewesson PJ.

Ann Pharmacother. 1995 Nov;29(11):1081-7.

PMID:
8573948
25.

Aprotinin reduces the need for blood products during liver transplantation.

Scudamore CH, Randall TE, Jewesson PJ, Shackleton CR, Salvian AJ, Fagan M, Frighetto L, Growe GH, Scarth I, Erb SR.

Am J Surg. 1995 May;169(5):546-9.

PMID:
7538269
26.

Ciprofloxacin use under a reserved drug and stepdown promotion program.

Frighetto L, Martinusen SM, Mamdani F, Jewesson PJ.

Can J Hosp Pharm. 1995 Feb;48(1):35-42.

PMID:
10141061
27.

A retrospective evaluation of imipenem use in bone marrow transplant patients.

Leong WA, Jewesson PJ.

Clin Ther. 1994 Sep-Oct;16(5):753-66; discussion 752.

PMID:
7859235
28.

Implementation and evaluation of a standardized herpes simplex virus prophylaxis protocol on a leukemia/bone marrow transplant unit.

Rayani SA, Nimmo CJ, Frighetto L, Martinusen SM, Nickoloff DM, Reece DE, Jewesson PJ.

Ann Pharmacother. 1994 Jul-Aug;28(7-8):852-6.

PMID:
7949499
29.

Amphotericin B use in a major acute care hospital.

Nicholl T, Phillips P, Jewesson PJ.

Clin Ther. 1994 Jan-Feb;16(1):28-40; discussion 27.

PMID:
8205599
30.

Documenting pharmacists' activities in the health record: a mechanism to provide ongoing quality assurance.

Nimmo CR, Jewesson PJ.

Ann Pharmacother. 1993 Nov;27(11):1405-6. No abstract available.

PMID:
8286823
31.

Comparison of cefoxitin and ceftizoxime in a hospital therapeutic interchange program.

Martinusen S, Chen D, Frighetto L, Bunz D, Stiver HG, Jewesson PJ.

CMAJ. 1993 Apr 1;148(7):1161-9.

32.

Teicoplanin versus vancomycin in the empirical treatment of febrile neutropenic patients.

Chow AW, Jewesson PJ, Kureishi A, Phillips GL.

Eur J Haematol Suppl. 1993;54:18-24. Review.

PMID:
8365461
33.

Intravenous-to-oral stepdown program: four years of experience in a large teaching hospital.

Frighetto L, Nickoloff D, Martinusen SM, Mamdani FS, Jewesson PJ.

Ann Pharmacother. 1992 Nov;26(11):1447-51.

PMID:
1477451
34.

A critical reevaluation of the "therapeutic range" of aminoglycosides.

McCormack JP, Jewesson PJ.

Clin Infect Dis. 1992 Jan;14(1):320-39. Review.

PMID:
1571447
35.

Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicity.

Kureishi A, Jewesson PJ, Rubinger M, Cole CD, Reece DE, Phillips GL, Smith JA, Chow AW.

Antimicrob Agents Chemother. 1991 Nov;35(11):2246-52.

36.

Application of a modified bioassay for monitoring serum teicoplanin and vancomycin in febrile neutropenic patients.

Kureishi A, Jewesson PJ, Bartlett KH, Cole CD, Chow AW.

Antimicrob Agents Chemother. 1990 Sep;34(9):1642-7.

37.

Simple ways to promote cost containment.

Bunz DM, Frighetto L, Gupta S, Jewesson PJ.

DICP. 1990 May;24(5):546. No abstract available.

PMID:
2343599
38.

Adverse reactions in a dose-ranging study with a new long-acting fluoroquinolone, fleroxacin.

Bowie WR, Willetts V, Jewesson PJ.

Antimicrob Agents Chemother. 1989 Oct;33(10):1778-82.

39.

Facilitating drug-use evaluation with database and other software.

Jewesson PJ.

Am J Hosp Pharm. 1989 Aug;46(8):1549. No abstract available.

PMID:
2773956
40.

Impact of a two-stage intervention program on cefazolin usage at a major teaching hospital.

Gupta S, Bachand RL, Jewesson PJ.

Hosp Formul. 1989 Jan;24(1):41-4, 46.

PMID:
10291599
41.

Kinetics of intraventricular vancomycin in infections of cerebrospinal fluid shunts.

Reesor C, Chow AW, Kureishi A, Jewesson PJ.

J Infect Dis. 1988 Nov;158(5):1142-3. No abstract available.

PMID:
3183426
42.

Unique two-stage intervention to modify prescribing trends.

Gupta S, Bachand RL, Jewesson PJ.

Drug Intell Clin Pharm. 1988 Sep;22(9):726-7. No abstract available.

PMID:
3215122
43.

Drug usage review of cefamandole at a teaching hospital.

Zaremba CD, Bachand RL, Chow AW, Jewesson PJ.

Can J Hosp Pharm. 1988 Aug;41(4):195-99, 214.

PMID:
10288851
44.

Use and safety of antimicrobial agents during pregnancy.

Chow AW, Jewesson PJ.

West J Med. 1987 Jun;146(6):761-4. No abstract available.

45.

Influence of blood collection tubes on tricyclic antidepressant concentration.

Jewesson PJ, Remick RA.

J Clin Psychopharmacol. 1986 Feb;6(1):51-2. No abstract available.

PMID:
3950068
46.

The influence of a hospital pharmacy residency program on career advancement and satisfaction.

Ensom RJ, Jewesson PJ.

Can J Hosp Pharm. 1985 Jun;38(3):90-3.

PMID:
10274969
47.

Pharmacokinetics and safety of antimicrobial agents during pregnancy.

Chow AW, Jewesson PJ.

Rev Infect Dis. 1985 May-Jun;7(3):287-313. Review.

PMID:
3895351
48.

Quality of use of parenteral metronidazole therapy in a teaching hospital.

Jewesson PJ, Bachand RL, Bell GA, Ensom RJ, Chow AW.

Can Med Assoc J. 1985 Apr 1;132(7):785-9.

49.

Influence of body fat on the volume of distribution of theophylline.

Jewesson PJ, Ensom RJ.

Ther Drug Monit. 1985;7(2):197-201.

PMID:
4024213
50.

Auditing antibiotic use in a teaching hospital: focus on cefoxitin.

Jewesson PJ, Ho R, Jang Q, Watts G, Chow AW.

Can Med Assoc J. 1983 May 1;128(9):1075-8.

Supplemental Content

Loading ...
Support Center